Stay updated with breaking news from Lars Nieba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Engimmune Therapeutics AG ("Engimmune"), a world-class developer of soluble T-cell receptor drugs ('TCRs') to treat solid tumours, is pleased...
Dr. Søren Mouritsen, co-founder of Engimmune, steps down as Chief Executive Officer in planned transitionBASEL, Switzerland, April 19, 2023 /PRNewswire/ -- Engimmune Therapeutics AG ("Engimmune")
OSLO, Norway, March 11, 2022 /PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 10 March 2022 decided to grant 934,000 Performance
/PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 10 March 2022 decided to grant 934,000...
/PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 10 March 2022 decided to grant 934,000...